Signal Coordinating Therapy, Inc.
Records under this name other than patents Signal Coordinating Therapy, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to Signal Coordinating Therapy, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,977,169 | Methods and compositions for treating neoplasms Term ended Term ended Apr 5, 2021 · From the USPTO record | Term ended | Term ended Apr 5, 2021 | From the USPTO record |
| US 7,842,314 | Methods and compositions for treating neoplasms Lapsed on the fee record Ended Nov 30, 2018 · From the USPTO record | Lapsed on the fee record | Ended Nov 30, 2018 | From the USPTO record |
| US 4,521,405 | Methods and materials for treatment of disease states involving immunological factors Term ended Term ended no later than Jun 4, 2005 · Low confidence | Term ended | Term ended no later than Jun 4, 2005 | Low confidence |
| US 4,705,685 | Methods and materials for treatment of disease states involving immunological factors Term ended Term ended no later than Nov 10, 2007 · Low confidence | Term ended | Term ended no later than Nov 10, 2007 | Low confidence |
| US 5,558,863 | Method for treatment of herpes virus infections Formerly held Term ended Term ended no later than Sep 24, 2016 · Low confidence | Term ended | Term ended no later than Sep 24, 2016 | Low confidence |
| US 5,645,997 | Assay and treatment for demyelinating diseases such as multiple sclerosis, related hybridomas and monoclonal antibodies Term ended Term ended no later than Jul 8, 2017 · Low confidence | Term ended | Term ended no later than Jul 8, 2017 | Low confidence |
| US 5,736,133 | Method and composition for the treatment of a individual infected with an immunodeficiency virus Formerly held Term ended Term ended no later than Apr 7, 2018 · Low confidence | Term ended | Term ended no later than Apr 7, 2018 | Low confidence |
| US 5,804,188 | Method and composition for treatment of disorders involving immunological dysfunction Formerly held Term ended Term ended no later than Sep 8, 2018 · Low confidence | Term ended | Term ended no later than Sep 8, 2018 | Low confidence |
| US 5,846,532 | Method and composition for the treatment of disorders involving immunological dysfunction Formerly held Term ended Term ended no later than Dec 8, 2018 · Low confidence | Term ended | Term ended no later than Dec 8, 2018 | Low confidence |
| US 5,883,227 | Multiple sclerosis associated polypeptide Term ended Term ended no later than Mar 16, 2019 · Low confidence | Term ended | Term ended no later than Mar 16, 2019 | Low confidence |